In the impressive conference center of the Milad Tower rising over Tehran’s roofs the 16th Energy Globe World Awards have been handed over in an international gala. Vice President Mrs. Masoumeh Ebtekar referred in her speech to the importance of such awards for outstanding environmental projects and their implementation. This event is the starting signal for intensified efforts concerning sustainability in Iran which is underlined by an expansion program for Renewables and energy efficiency. Also Maneka Gandhi emphasized that a sustainable change in our world can’t be achieved by talks or laws but only by taking action as showed by the Energy Globe submissions.
Nobel Peace Prize Laureate and presenter Prof. Munasinghe said: It is necessary that poor and rich countries take each other’s hand in order to exchange experiences and support each other.
3 nominees respectively from all 5 continents competed in the 5 categories Earth, Water, Fire, Air and Youth. The nominees have been chosen from around 2000 submissions from 177 countries.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7740251-masoumeh-ebtekar-awarded-best-projects/
Isle of Capri Casinos, Inc. (NASDAQ:ISLE) today announced the winners of its second charitable social media contest awarding a share of $50,000 to five local nonprofit organizations.
Southern Heritage Air Foundation - $25,000 – Tallulah, Louisiana
Family and Youth Opportunities Division - $15,000 – Clarksdale, Mississippi
Fayette Community Service Organization - $5,000 – Fayette, Mississippi
Guttenberg Gallery & Creativity Center - $2,500 – Guttenberg, Iowa
Walking In The Sun Rescue - $2,500 – Collinston, Louisiana
“With over 69,000 votes cast in Community Aces Challenge and over 200 applications to participate, our second charitable social media contest has proven to be a wonderful way to give back to the communities where we operate,” said Virginia McDowell, Isle’s president and chief executive officer.
“The 123 participating nonprofit organizations registered in January and coordinated their own individual voting campaigns which ended on April 1,” said McDowell. “This year the winners offered a wide variety of missions – from getting fit in rural Mississippi to enhancing creativity of young people in Iowa. Our first place winner is dedicated to educating people about the history and impact of aviation and our second place winner is refurbishing an old school to become a community center.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7805451-isle-of-capri-casinos-community-aces-challenge/
GB Sciences, Inc. (OTCQB: GBLX) announces the success of its first annual, “Innovation in Medical Cannabis Therapies” (IMCT) Symposium, held on Friday, November 9th at the “Keep Memory Alive” Event Center at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada. Throughout the day’s program, there was an emerging sense of heightened responsibility on the part of the cannabis industry to better address medical cannabis patients' needs through research and development of medical cannabis products that are better standardized, more easily-dosed, and made more widely-available to cannabis patients at a fair price.
To view the multimedia release go to:
https://www.multivu.com/players/English/8308958-gb-sciences-2018-medical-cannabis-therapies-symposium/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Providence Place at the center for higher independence help the young adults with disabilities gain the work, life and social skills to live independently.
The tourism Authority of Thailand or TAT organize a press conference at Queen Sirikit National Convention Center on July 8, 2013 to announce the Action plan for 2014 to the private sector as well as local and international media. For 2014 , TAT has set a target of 28 Million international tourists which will bring in the revenue of 1.3 trillion baht, More than 135 % for this year. This year, The core theme of Higher Revenue through Thainess will be emphized and implemented via marketing strategies. This concept will traget custormer segments to experience Thai way of life and Thai cluture.
Cantor Fitzgerald, a leading financial services firm, today announced that Cantor Fitzgerald, together with its affiliate BGC Partners, Inc., raised approximately $12 million for dozens of charities around the world, at the companies’ annual Charity Day on September 11, 2015. Each year, Cantor Fitzgerald and BGC Partners donate 100% of the global revenues generated on Charity Day to the Cantor Fitzgerald Relief Fund, and to date has raised approximately $125 million globally since its inception.
“We will never forget all of our friends and colleagues who perished on 9/11. Charity Day represents our company’s fundamental commitment to helping others, and allows us to commemorate the events of that day. Giving back is our way of remembering those who lost their lives on 9/11, turning a day of tragedy into a positive and uplifting day for our employees and friends,” said Howard W. Lutnick, Chairman and Chief Executive Officer of Cantor Fitzgerald, L.P. and BGC Partners.
Charity Day is held in commemoration of the 658 Cantor employees and 61 Eurobrokers employees lost in the 9/11 World Trade Center attacks.
To view the multimedia release go to:
http://www.multivu.com/players/English/7620751-cantor-bgc-partners-charity-day-2015/
Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.
It is estimated that almost 40 percent of men and women in the U.S. will be diagnosed with cancer sometime during their lifetime. Kommah, who was diagnosed at age 29, now has her health and her son, thanks to discoveries made at City of Hope, where scientists and doctors turn laboratory breakthroughs into treatments that defeat cancer.
Today, the nonprofit research and comprehensive cancer center near Los Angeles is rolling out a new initiative that builds on its legacy of discovery to let people know that City of Hope not only offers a uniquely patient-centric, integrated approach to care, but also with the help of donors and volunteers, it is pursuing research that will change the future of medicine.
To view the multimedia release go to:
http://www.multivu.com/players/English/7665051-city-of-hope-miracle-science-soul-campaign/
Turning your clocks ahead an hour on March 8 for the start of Daylight Savings Time may be known as the unofficial start to spring, but for many, it’s known as the day we lose an hour of sleep. As you prepare to change your clocks on Sunday, take that opportunity to evaluate your sleeping habits. The loss of that hour of sleep can turn minor sleep issues into major ones.
“When we move our clock forward or backward, our internal clock becomes out of sync with the external time,” says Dr. Daniel Shade, Board Certified Sleep Specialist and Director of the AHN Sleep Disorders Center. “The best way to combat this is to expose ourselves to light and let our bodies resynchronize.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7447951-remworks-daylight-savings-sleep-coach/
The STIHL® TIMBERSPORTS® Series announced today that the premier U.S. lumberjack sporting event will be held outside one of the biggest cities in the United States – Chicago. The Series’ U.S. Pro and Collegiate Championships will be held at the Tinley Park Convention Center, located in Chicago Southland, on July 15 and 16.
The STIHL® TIMBERSPORTS® Series – The Original Extreme Sport – pits the top lumberjack athletes from across the country in thrilling and grueling wood chopping, cutting, and sawing competitions. For the third straight year, the Championships will air on the ABC network in the fall. The Professional Series will also re-air on ESPN and ESPN2.
To view the multimedia release go to:
http://www.multivu.com/players/English/7760851-stihl-timbersports-2016-announcement/
The Celiac Disease Center at Columbia University, the premier center for celiac disease research and treatment, unveiled the I Didn’t Know video campaign, offering an inside look at the serious impact of celiac disease on patients at the 13th Anniversary gala on November 13th in New York City. The series chronicles the lives of several patients experiencing a wide range of debilitating symptoms associated with undiagnosed celiac disease, including an inability to walk, developmental delays, multiple miscarriages and infertility.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7322351-celiac-disease-center-at-columbia-university-public-service-announcements-and-gala/
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
